EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 68 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,902 | -33.7% | 945 | -18.3% | 0.00% | -100.0% |
| Q2 2023 | $22,492 | +224820.0% | 1,157 | +217.0% | 0.00% | – |
| Q1 2023 | $10 | 0.0% | 365 | +2.2% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 357 | -95.5% | 0.00% | -100.0% |
| Q3 2022 | $211,000 | +305.8% | 7,957 | +578.3% | 0.00% | +200.0% |
| Q2 2022 | $52,000 | -59.7% | 1,173 | -55.2% | 0.00% | 0.0% |
| Q1 2022 | $129,000 | -33.5% | 2,617 | -31.2% | 0.00% | -66.7% |
| Q4 2021 | $194,000 | +203.1% | 3,805 | +230.6% | 0.00% | +50.0% |
| Q3 2021 | $64,000 | +93.9% | 1,151 | +50.3% | 0.00% | +100.0% |
| Q2 2021 | $33,000 | -21.4% | 766 | -24.7% | 0.00% | 0.0% |
| Q1 2021 | $42,000 | +366.7% | 1,017 | +441.0% | 0.00% | – |
| Q4 2020 | $9,000 | -71.9% | 188 | -75.4% | 0.00% | – |
| Q3 2020 | $32,000 | -67.7% | 765 | -63.0% | 0.00% | -100.0% |
| Q2 2020 | $99,000 | +2375.0% | 2,066 | +1886.5% | 0.00% | – |
| Q4 2018 | $4,000 | -85.2% | 104 | -71.3% | 0.00% | -100.0% |
| Q2 2018 | $27,000 | -73.8% | 362 | -81.5% | 0.00% | -77.8% |
| Q1 2018 | $103,000 | +692.3% | 1,958 | +695.9% | 0.01% | +350.0% |
| Q4 2017 | $13,000 | -59.4% | 246 | -37.1% | 0.00% | -33.3% |
| Q1 2017 | $32,000 | -68.9% | 391 | -69.9% | 0.00% | -72.7% |
| Q4 2016 | $103,000 | +10200.0% | 1,300 | +4233.3% | 0.01% | – |
| Q1 2016 | $1,000 | -88.9% | 30 | -70.0% | 0.00% | -100.0% |
| Q4 2015 | $9,000 | -87.3% | 100 | -89.5% | 0.00% | -85.7% |
| Q3 2015 | $71,000 | +1320.0% | 954 | +657.1% | 0.01% | +600.0% |
| Q1 2015 | $5,000 | +25.0% | 126 | -52.8% | 0.00% | – |
| Q4 2014 | $4,000 | -84.0% | 267 | -86.4% | 0.00% | -100.0% |
| Q3 2014 | $25,000 | +212.5% | 1,966 | +222.3% | 0.00% | +200.0% |
| Q1 2014 | $8,000 | – | 610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |